Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis

  • Andrew R. Moore,
  • Malcolm Boyce,
  • Islay A. Steele,
  • Fiona Campbell,
  • Andrea Varro,
  • D. Mark Pritchard
  • Article
  • Metrics
  • Comments
  • Media Coverage

As a result of an error in the production process, a duplicate of Figure 5 appears in place of Figure 4. The correct version of Figure 4 is available here:

thumbnail
Download:

The legend for Figure 4 is correct.

Citation: Moore AR, Boyce M, Steele IA, Campbell F, Varro A, Pritchard DM (2013) Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis. PLoS ONE 8(11): 10.1371/annotation/4afd48b1-8dc0-47cc-9c8a-99aba7623116. https://doi.org/10.1371/annotation/4afd48b1-8dc0-47cc-9c8a-99aba7623116

Published: November 1, 2013

Copyright: © 2013 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Competing interests: No competing interests declared.